-
Shkreli, a former pharmaceutical executive known for raising the price of a life-saving drug by 5,000%, was sentenced to seven years in prison for securities fraud in 2018.
-
Martin Shkreli, who is serving a seven-year prison sentence for fraud, must return profits he and his former company reaped from raising the price of a lifesaving drug, a federal judge ruled.
-
There was only one copy of Once Upon a Time in Shaolin, and the government forced Shkreli to turn it over after his fraud conviction. Details are confidential, so don't expect to hear it anytime soon.
-
Shkreli argues that his pharmaceuticals experience qualifies him to help seek a treatment or cure. Probation officials call that claim "delusional self-aggrandizing behavior."
-
Nearly 1 in 4 Americans has trouble affording prescription drugs, according to a Kaiser Family Foundation poll. Over the past decade, high prices of several medicines have become flashpoints.
-
In addition to ordering Shkreli to stay in prison, a federal appeals court also affirmed that he must forfeit more than $7.3 million and pay restitution of $388,336.
-
A judge has ruled that the former pharmaceutical chief known as "Pharma Bro" owes the government $7.36 million for his fraud. And if he can't pay it back, he'll have to give up the ultra-rare album.
-
Shkreli, convicted of securities fraud, will await sentencing in jail after a federal judge called him an "ongoing risk to the community."
-
Martin Shkreli awaits a verdict on a series of fraud and conspiracy charges related to his time as a hedge fund manager.
-
The former pharmaceutical executive — who earned notoriety for jacking up the price of a life-saving drug — spoke to a student group Wednesday night, though about a tenth of his audience walked out.